China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
42.06
+0.17 (0.41%)
May 13, 2025, 2:45 PM CST
SHE:000999 Revenue
China Resources Sanjiu Medical & Pharmaceutical had revenue of 6.85B CNY in the quarter ending March 31, 2025, with 11.79% growth. This brings the company's revenue in the last twelve months to 27.18B, up 5.82% year-over-year. In the year 2024, China Resources Sanjiu Medical & Pharmaceutical had annual revenue of 27.62B with 11.63% growth.
Revenue (ttm)
27.18B
Revenue Growth
+5.82%
P/S Ratio
1.98
Revenue / Employee
1.36M
Employees
20,031
Market Cap
53.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.62B | 2.88B | 11.63% |
Dec 31, 2023 | 24.74B | 6.66B | 36.83% |
Jan 1, 2023 | 18.08B | 2.54B | 16.31% |
Jan 1, 2022 | 15.54B | 1.91B | 13.98% |
Dec 31, 2020 | 13.64B | -1.16B | -7.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |